Trump to End Medicare D Subsidy After 2026
Trump administration will end subsidy for Medicare Part D prescription drug plans after 2026, citing insurers' ability to price without support.
Trump to End Medicare D Subsidy After 2026
The Trump administration announced on July 29 that it will end the subsidy program for Medicare Part D prescription drug plans effective from 2027. This decision comes as a result of the Centers for Medicare & Medicaid Services (CMS) review showing that insurers have gained enough experience to accurately price their plans without government assistance. The agency stated this move aims to stabilize the market and eliminate the need for continued subsidies.
Trump Administration to End Medicare Part D Subsidy After 2026
The Trump administration has announced that it will end the Medicare Part D subsidy program after 2026. The program was introduced to keep premiums stable for Medicare prescription drug plans, but the administration has decided that it is no longer necessary. The Centers for Medicare & Medicaid Services said that insurers have gained enough experience with Medicare Part D to accurately price their plans without support from the program. The decision is expected to have a significant impact on the healthcare industry and the millions of Americans who rely on Medicare for their prescription drug coverage.